Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:TFFPNASDAQ:VINCNASDAQ:VRPXOTCMKTS:WCUI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeTFFPTFF Pharmaceuticals$0.07$0.06$0.06▼$3.23N/A0.98868,901 shsN/AVINCVincerx Pharma$0.05+4.9%$0.09$0.04▼$17.17$283K1.75431,967 shs18,744 shsVRPXVirpax Pharmaceuticals$0.28+3.7%$0.25$0.13▼$84.75$347K1.48201,218 shs13,936 shsWCUIWellness Center Usa$0.00$0.00$0.00▼$0.00$90K4.97N/AN/ATen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceTFFPTFF Pharmaceuticals0.00%0.00%0.00%0.00%-96.67%VINCVincerx Pharma+4.85%+11.34%+12.27%-91.29%-99.55%VRPXVirpax Pharmaceuticals+3.72%+7.27%+26.82%-88.83%-98.04%WCUIWellness Center Usa0.00%0.00%+450.00%+450.00%+10.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationTFFPTFF PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/AVINCVincerx Pharma3.6135 of 5 stars3.55.00.00.02.81.71.3VRPXVirpax Pharmaceuticals1.5857 of 5 stars3.04.00.00.00.60.00.6WCUIWellness Center UsaN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceTFFPTFF Pharmaceuticals 0.00N/AN/AN/AVINCVincerx Pharma 3.00Buy$40.0073,974.07% UpsideVRPXVirpax Pharmaceuticals 2.00Hold$75.0026,781.72% UpsideWCUIWellness Center Usa 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookTFFPTFF Pharmaceuticals$730K0.40N/AN/A$4.04 per share0.02VINCVincerx PharmaN/AN/AN/AN/A$10.50 per shareN/AVRPXVirpax PharmaceuticalsN/AN/AN/AN/A$1.65 per shareN/AWCUIWellness Center Usa$660K0.12N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateTFFPTFF Pharmaceuticals-$21.24M-$6.44N/A∞N/A-1,596.64%-310.17%-196.06%N/AVINCVincerx Pharma-$40.16M-$20.60N/AN/AN/AN/A-248.33%-132.73%8/6/2025 (Estimated)VRPXVirpax Pharmaceuticals-$15.19MN/A0.00∞N/AN/A-1,554.34%-338.29%N/AWCUIWellness Center Usa-$750KN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthTFFPTFF PharmaceuticalsN/AN/AN/AN/AN/AVINCVincerx PharmaN/AN/AN/AN/AN/AVRPXVirpax PharmaceuticalsN/AN/AN/AN/AN/AWCUIWellness Center UsaN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioTFFPTFF PharmaceuticalsN/A0.890.89VINCVincerx PharmaN/A2.172.17VRPXVirpax PharmaceuticalsN/A0.130.13WCUIWellness Center UsaN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipTFFPTFF Pharmaceuticals15.25%VINCVincerx Pharma44.02%VRPXVirpax Pharmaceuticals32.23%WCUIWellness Center Usa0.01%Insider OwnershipCompanyInsider OwnershipTFFPTFF Pharmaceuticals4.50%VINCVincerx Pharma15.60%VRPXVirpax Pharmaceuticals3.70%WCUIWellness Center Usa15.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableTFFPTFF Pharmaceuticals194.44 million4.24 millionOptionableVINCVincerx Pharma605.23 million1.89 millionNot OptionableVRPXVirpax Pharmaceuticals71.24 million4.71 millionNot OptionableWCUIWellness Center Usa8143.19 million120.71 millionNot OptionableWCUI, TFFP, VINC, and VRPX HeadlinesRecent News About These Companies‘Shocked’: North Portland Wellness Center scorched by 3-alarm fireJune 10, 2025 | msn.comWildcat Wellness Center set to close in July for summer breakJune 4, 2025 | msn.comSenior wellness expo draws increased attendance at YMCA Wellness CenterMay 21, 2025 | msn.comLumiClinics Behavioral Wellness Center Revolutionizes Mental Health Care with Integrated ApproachMay 18, 2025 | news.marketersmedia.comCancer Wellness Center of NEPA holds Annual WalkMay 12, 2025 | timesleader.comCancer Wellness Center gears up for major walk fundraiserMay 8, 2025 | msn.comWellness Center attendance upApril 16, 2025 | sdsucollegian.comMCCTC Plans New Health and Wellness CenterApril 11, 2025 | businessjournaldaily.comRegional Wellness Center project planning on pause amid funding uncertaintyApril 11, 2025 | duboiscountyfreepress.comVictorville’s Wellness Center receives major funding from San Bernardino CountyApril 11, 2025 | msn.comUSD To Host Wellness Center Natatorium Grand Opening And Ribbon CuttingApril 11, 2025 | plaintalk.netSam Raan Spa & Wellness Center Wins a 2025 Global Recognition Award for Exceptional Service ExcellenceMarch 31, 2025 | news.marketersmedia.comAgeWell Services continuing its mission despite Wellness Center and Cafe closureMarch 28, 2025 | msn.comMultimillion dollar transformation set for Norfolk Fitness and Wellness CenterMarch 28, 2025 | wtkr.comAgeWell Services will close Wellness Center, Driftwood Café amid budget concernsMarch 27, 2025 | msn.comMid-America Carpenters Regional Council and Premise Health Celebrate Grand Opening of Kansas City Wellness CenterMarch 12, 2025 | finance.yahoo.comNASCAR Legends Jimmie Johnson, Richard Petty Spotted at Martin Truex Jr.’s Late Partner’s Wellness Center OpeningFebruary 16, 2025 | msn.comChamber holds ribbon cutting for Women’s Wellness CenterJanuary 24, 2025 | thepostsearchlight.comSkidmore's McCaffery-Wagman Tennis and Wellness Center opensJanuary 23, 2025 | poststar.comKing County approves funding for Ron Chew Healthy Aging and Wellness CenterJanuary 23, 2025 | nwasianweekly.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeWCUI, TFFP, VINC, and VRPX Company DescriptionsTFF Pharmaceuticals NASDAQ:TFFP$0.06 0.00 (0.00%) As of 04/10/2025TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment and prophylaxis of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It also develops other dry powder products, such as Augmenta human derived monoclonal antibodies for the treatment of COVID-19 disease; and other vaccines. It has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs. TFF Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Fort Worth, Texas.Vincerx Pharma NASDAQ:VINC$0.05 +0.00 (+4.85%) As of 06/18/2025 03:33 PM EasternVincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.Virpax Pharmaceuticals NASDAQ:VRPX$0.28 +0.01 (+3.72%) As of 06/18/2025 03:10 PM EasternVirpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and NobrXiol, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.Wellness Center Usa OTCMKTS:WCUI$0.0006 0.00 (0.00%) As of 06/17/2025Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Chime’s Smart IPO: Half the Valuation, Double the Strength Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Tesla Bulls and Bears Collide: What Investors Should Know Qualcomm: A Technical Setup Is Emerging, and It's Bullish 330% Returns YTD: Is CoreWeave's Momentum Softening? Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks 3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated Microsoft-OpenAI Rift May Cap Stock Upside Potential Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
